Kensuke Naito

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

W Zhang, Kazunori Ohnishi, Kohichiro Shigeno et al. · Leukemia · 1998 · 160 citations

Life Sciences, Cell Biology, Oncology +16

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno et al. · Leukemia · 2000 · 152 citations

Medicine, Oncology, Pharmacology +11

Clinicopathological and prognostic characteristics of CD56‐negative multiple myeloma

Akihiro Takeshita, Kazuyuki Shigeno, Shinya Fujisawa et al. · British Journal of Haematology · 2002 · 147 citations

Medicine, Hematology, Pathology +10

Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission Therapies

Kazuyuki Shigeno, Kensuke Naito, Miki Kobayashi et al. · International Journal of Hematology · 2005 · 112 citations

Medicine, Hematology, Oncology +9

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

Hirotaka Matsui, Akihiro Takeshita, Kensuke Naito et al. · Leukemia · 2002 · 104 citations

Medicine, Oncology, Pharmacology +15